A study of the efficacy and safety of albendazole (Zentel) in the treatment of intestinal helmenthiasis in Kenyan children less than 2 years of age. East Afr Med J . 1989 Mar; 66 ( 3 ): 197-202 . PMID: 2591328 [PubMed - indexed for MEDLINE] Pamba HO, Bwib

Citation:
O PROFBWIBONIMROD. "A study of the efficacy and safety of albendazole (Zentel) in the treatment of intestinal helmenthiasis in Kenyan children less than 2 years of age. East Afr Med J . 1989 Mar; 66 ( 3 ): 197-202 . PMID: 2591328 [PubMed - indexed for MEDLINE] Pamba HO, Bwib.". In: East Afr Med J . 1989 Mar; 66 ( 3 ): 197-202 . Anim. Hlth. Prod. Afr. 2008; 1989.

Abstract:

One hundred children comprising of 57 males and 43 females aged between 8 and 24 months entered the study. 46 children had single and 54 children had multiple helminth infections. All children received albendazole 200 mg (10 ml) suspension as a single dose. Albendazole proved very effective and safe in the treatment of single and multiple helminth infections in children under 2 years of age, achieving cure rates of 100% in both Ascaris lumbricoides and Necator americanus respectively, 83% in Trichuris trichiura and 66% in Hymenolepis nana. Treatment of polyparasitism appears to be of benefit in improving nutritional status using haemoglobin concentrations as an index.

PMID: 2591328 [PubMed - indexed for MEDLINE]

Notes:

n/a

Website

UoN Websites Search